Whereas, Pomeroy and colleagues found that NRAS-driven AML cell line relapsed after genetic suppression on NRAS (NRI-AML) was devoid of MAPK and PI3K signaling but dependent on the cyclin-dependent kinase (CDK) 5-mediated activation of RalGEF signaling. This evidence concerns the gene RALGDS and acute myeloid leukemia.